Colgate-Palmolive Q2 2025 Results Show Growth Amid Rising Costs and Margin Pressures

Colgate-Palmolive Company (NYSE: CL) has released its financial results for Q2 2025, showing both resilience and areas of concern within its operations.

Positive Aspects:

• Net Sales: $5,110 million, a 1.0% increase compared to Q2 2024.
• Net Income: $743 million, up from $731 million in the same quarter last year.
• Earnings Per Share (EPS): Increased to $0.91 (diluted) vs $0.89 in Q2 2024.
• Gross Profit: $3,069 million, up slightly from $3,066 million, indicating stable profitability.
• Acquisition Impact: The acquisition of Care TopCo Pty Ltd has begun contributing positively to segment growth.

Negative Aspects:

• Cost of Sales: Increased to $2,041 million from $1,992 million, reflecting rising raw material costs.
• Gross Profit Margin: Down to 60.1% from 60.6%, indicating reduced efficiency in converting sales into profit.
• Selling, General and Administrative Expenses: Saw a marginal increase to $1,963 million, leading to a slight rise as a percentage of net sales.
• Operating Profit: Decreased by 1% to $1,080 million, with operating margin dropping from 21.6% to 21.1% due to higher costs and lower price realization.
• FCF Pressure: Net cash provided by operations decreased by 11% to $1,484 million compared to the same period last year.

Key Financial Metrics:

• Net Sales (Q2 2025): $5,110 million (Q2 2024: $5,058 million)
• Net Income: $743 million (Q2 2024: $731 million)
• Gross Profit: $3,069 million (Q2 2024: $3,066 million)
• Operating Profit: $1,080 million (Q2 2024: $1,092 million)
• EPS (Diluted): $0.91 (Q2 2024: $0.89)
• Gross Profit Margin: 60.1% (Q2 2024: 60.6%)

Outlook: The company acknowledges potential challenges ahead including inflationary pressures, geopolitical tensions, and foreign exchange volatility. Despite these challenges, Colgate remains focused on its sustainability strategy and operational efficiencies to enhance long-term growth.